Life Bioscience Enters 'Competitive' Slide Market with 3D Glass Microarrays | GenomeWeb

By Justin Petrone

Life Bioscience, a three-year-old startup based in Albuquerque, NM, last week launched a menu of slides to meet the needs of the growing protein array market.

Tim Foster, vice president of marketing and sales at LBSI, said that the firm's new Oracle 3D glass nanowell microarray substrates are targeted towards customers that use protein arrays for research, in drug discovery, and, potentially, in the clinic.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.